Related content

Combined curative radiotherapy including HDR brachytherapy and androgen deprivation in localized prostate cancer: A prospective assessment of acute and late treatment toxicity

By Wahlgren Thomas   Nilsson Sten   Ryberg Marianne   Lennernäs Bo   Brandberg Yvonne  

Acta Oncologica, Vol. 44, Iss. 6, 2005-09 ,pp. : 633-643

Informa Healthcare

Access to resources Recommend Favorite

Living alone, obesity and smoking: Important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer

By Dieperink Karin B.   Hansen Steinbjørn   Wagner Lis   Johansen Christoffer   Andersen Klaus K.   Hansen Olfred  

Acta Oncologica, Vol. 51, Iss. 6, 2012-07 ,pp. : 722-729

Informa Healthcare

Access to resources Recommend Favorite

Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases

By Schick Ulrike   Jorcano Sandra   Nouet Philippe   Rouzaud Michel   Vees Hansjoerg   Zilli Thomas   Ratib Osman   Weber Damien C.   Miralbell Raymond  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1622-1628

Informa Healthcare

Access to resources Recommend Favorite

Stereotactic Body Radiotherapy (SBRT) in the Management of Clinically Localized Prostate Cancer: Where are We Now?

By  

Current Cancer Therapy Reviews, Vol. 14, Iss. 1, 2018-02 ,pp. : 31-45

Bentham Science Publishers

Access to resources Recommend Favorite

Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpoints

By Oh W.K.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 3, 2003-05 ,pp. : 229-234

Elsevier

Access to resources Recommend Favorite